These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18070926)

  • 1. Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells.
    Fritah A; Saucier C; De Wever O; Bracke M; Bièche I; Lidereau R; Gespach C; Drouot S; Redeuilh G; Sabbah M
    Mol Cell Biol; 2008 Feb; 28(3):1114-23. PubMed ID: 18070926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
    Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
    Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2.
    Dhar G; Banerjee S; Dhar K; Tawfik O; Mayo MS; Vanveldhuizen PJ; Banerjee SK
    Cancer Res; 2008 Jun; 68(12):4580-7. PubMed ID: 18559502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.
    Ferrand N; Stragier E; Redeuilh G; Sabbah M
    Biochem J; 2012 Oct; 447(1):71-9. PubMed ID: 22765757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WISP-2/CCN5 is involved as a novel signaling intermediate in phorbol ester-protein kinase Calpha-mediated breast tumor cell proliferation.
    Sengupta K; Banerjee S; Dhar K; Saxena NK; Mehta S; Campbell DR; Banerjee SK
    Biochemistry; 2006 Sep; 45(35):10698-709. PubMed ID: 16939222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.
    Dhar K; Banerjee S; Dhar G; Sengupta K; Banerjee SK
    Cancer Res; 2007 Feb; 67(4):1520-6. PubMed ID: 17308090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
    Fritah A; Redeuilh G; Sabbah M
    J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.
    Banerjee S; Dhar G; Haque I; Kambhampati S; Mehta S; Sengupta K; Tawfik O; Phillips TA; Banerjee SK
    Cancer Res; 2008 Sep; 68(18):7606-12. PubMed ID: 18794149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition.
    Dhar G; Mehta S; Banerjee S; Gardner A; McCarty BM; Mathur SC; Campbell DR; Kambhampati S; Banerjee SK
    Cancer Lett; 2007 Aug; 254(1):63-70. PubMed ID: 17383817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
    Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
    BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of MCF-7 tumor progression in athymic nude mice by 17beta-estradiol induces WISP-2/CCN5 expression in xenografts: a novel signaling molecule in hormonal carcinogenesis.
    Ray G; Banerjee S; Saxena NK; Campbell DR; Van Veldhuizen P; Banerjee SK
    Oncol Rep; 2005 Mar; 13(3):445-8. PubMed ID: 15706414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway.
    Sabbah M; Prunier C; Ferrand N; Megalophonos V; Lambein K; De Wever O; Nazaret N; Lachuer J; Dumont S; Redeuilh G
    Mol Cell Biol; 2011 Apr; 31(7):1459-69. PubMed ID: 21262769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells.
    Haque I; Banerjee S; Mehta S; De A; Majumder M; Mayo MS; Kambhampati S; Campbell DR; Banerjee SK
    J Biol Chem; 2011 Dec; 286(50):43475-85. PubMed ID: 22020939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.
    Banerjee S; Saxena N; Sengupta K; Tawfik O; Mayo MS; Banerjee SK
    Neoplasia; 2003; 5(1):63-73. PubMed ID: 12659671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.
    Ouelaa-Benslama R; De Wever O; Hendrix A; Sabbah M; Lambein K; Land D; Prévost G; Bracke M; Hung MC; Larsen AK; Emami S; Gespach C
    Int J Oncol; 2012 Jul; 41(1):189-200. PubMed ID: 22552300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.
    Das A; Dhar K; Maity G; Sarkar S; Ghosh A; Haque I; Dhar G; Banerjee S; Banerjee SK
    Sci Rep; 2017 Apr; 7(1):1220. PubMed ID: 28450698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WISP-2: a serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells.
    Zoubine MN; Banerjee S; Saxena NK; Campbell DR; Banerjee SK
    Biochem Biophys Res Commun; 2001 Mar; 282(2):421-5. PubMed ID: 11401475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of WISP-1 and WISP-2 genes in normal and transformed human breast cell lines.
    Saxena N; Banerjee S; Sengupta K; Zoubine MN; Banerjee SK
    Mol Cell Biochem; 2001 Dec; 228(1-2):99-104. PubMed ID: 11855747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer.
    Davies SR; Watkins G; Mansel RE; Jiang WG
    Ann Surg Oncol; 2007 Jun; 14(6):1909-18. PubMed ID: 17406949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.
    Haque I; Banerjee S; De A; Maity G; Sarkar S; Majumdar M; Jha SS; McGragor D; Banerjee SK
    Oncogene; 2015 Jun; 34(24):3152-63. PubMed ID: 25132260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.